Muutke küpsiste eelistusi

Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers [Pehme köide]

Edited by (Institute of Clinical Medicine, National Cheng Kung University, Taiwan), Edited by (Director of Internal Medicine at the National Cheng K), Edited by (Assistant Professor in the P.G. and Research Department of Chemistry at Cauvery College for Women, India)
  • Formaat: Paperback / softback, 504 pages, kõrgus x laius: 235x191 mm, kaal: 450 g
  • Ilmumisaeg: 02-Jun-2025
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0443330301
  • ISBN-13: 9780443330308
Teised raamatud teemal:
Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease BiomarkersSuurem pilt
  • Formaat: Paperback / softback, 504 pages, kõrgus x laius: 235x191 mm, kaal: 450 g
  • Ilmumisaeg: 02-Jun-2025
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0443330301
  • ISBN-13: 9780443330308
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9780443330308.html
Märksõnad:
Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers presents various aspects of nanomaterials-based optical biosensing for the detection of cardiovascular disease biomarkers. It begins by classifying cardiac biomarkers based on cardiovascular pathology, exploring tissue specificity, and discussing applications in composite risk prediction models. The subsequent chapters cover the selection of bioreceptors for biosensor systems, an overview of optical nanomaterials, and the design and integration of optical nanobiosensors. Various optical readout techniques, such as colorimetric, fluorescence, chemiluminescence, localized surface plasmon resonance (LSPR), and surface-enhanced Raman scattering (SERS), are examined for their advantages in nanobiosensors. Specific chapters delve into visible and colorimetric nanobiosensors, fluorescence-based nanobiosensors, nanomaterials-based chemiluminescence biosensors, LSPR biosensors, and SERS-based nanobiosensors for cardiovascular disease biomarkers. The book also covers ready-to-use point-of-care testing (PoCT) technologies, advancements in nanobiosensor-based PoCT for cardiovascular biomarkers, and the integration of artificial intelligence in nanomaterials-based optical biosensing. Regulatory and safety considerations for nanomaterials in PoCT applications are discussed, and the final chapter explores advancements in nanomaterials-based point-of-care diagnostic technologies on the path to clinical translation, emphasizing their potential impact on healthcare accessibility and accuracy.
1. An Overview of Novel Biomarkers for Cardiovascular Disease and Advances in Point-of-Care Diagnostics
2. Selection of Bioreceptors for Nanobiosensors: Fundamentals and Innovations in Point-of-Care Applications
3. Comprehensive Overview of Optical Nanomaterials: Fundamentals and Advantages of Biosensor Applications
4. Optical nanobiosensors: Design, Integration of Binding Receptors and Sensing Mechanisms
5. Optical Readout Techniques in Nanobiosensors: Fundamentals and Future Directions for Point-of-Care Applications
6. A Visible, Colorimetric Point-of-Care Nanobiosensor for the Detection of Cardiovascular Disease Biomarkers
7. Fluorescence-Based Point-of-Care Nanobiosensors for the Detection of Cardiovascular Disease Biomarkers
8. Nanomaterials-based Point-of-Care Chemiluminescence Biosensors for the Detection of Cardiovascular Disease Biomarkers
9. Localized Surface Plasmon Resonance-based Biosensor for Point-of-Care Detection of Cardiovascular Disease Biomarkers
10. Surface-Enhanced Raman Scattering-Based Nanobiosensors for Point-of-Care Detection of Cardiovascular Biomarkers
11. Emerging Healthcare Technologies for Next-Generation Portable Point-of-Care Testing Devices
12. Recent Advances in Point-of-Care Nanobiosensor Techniques for the Rapid Diagnosis of Cardiovascular Disease Biomarkers
13. The Role of Artificial Intelligence in Point-of-Care Diagnosis of Cardiovascular Diseases
14. Regulatory and Safety Considerations for Nanomaterial-Medical and Point-of-Care Diagnostic Devices
15. Nanomaterial-Based Point-of-Care Testing Devices for Cardiovascular Disease Biomarker: Advancing Technologies Toward Clinical Translation
Dr. Tharmaraj Vairaperumal, Postdoctoral Research Scientist at Institute of Clinical Medicine, National Cheng Kung University, Taiwan. His research expertise involves the development of advanced point-of-care testing technologies, focusing on portable microfluidic devices integrated with nanobiosensors for cardiovascular diagnostics.

Dr. Devi Selvaraj, Assistant Professor in the P.G. and Research Department of Chemistry at Cauvery College for Women, India. Her research focuses on the design and development of nanomaterial-based electrochemical biosensors for point-of-care testing applications.

Prof. Ping-Yen Liu, Director of Internal Medicine at National Cheng Kung University Hospital, and Affiliated Distinguished Professor at Division of Cardiology, Institute of Clinical Medicine, National Cheng Kung University, Taiwan. His research focuses on developing nanobiosensor-based PoCT technologies for cardiovascular diagnostics.